Fedratinib in patients with myelofibrosis previously treated with ruxolitinib Fedratinib in patients with myelofibrosis previously treated with ruxolitinib: An updated analysis of the JAKARTA2 study using stringent criteria for ruxolitinib failure Fedratinib in patients with myelofibrosis previously treated with ruxolitinib_ An updated analysis of the JAKARTA2 study using stringent criteria for ruxolitinib failure RETOUR MarcGuevreguian2021-03-22T19:45:58+01:00
